Small-fiber neuropathy definition, diagnosis, and treatment

Neurol Sci. 2019 Jul;40(7):1343-1350. doi: 10.1007/s10072-019-03871-x. Epub 2019 Apr 9.

Abstract

In the last 30 years, improvement of diagnostic methods enabled routine evaluation of small A-delta and C nerve fibers impairment, which results with the clinical condition known as a small-fiber neuropathy (SFN). This syndrome develops as a result of metabolic, toxic, immune-mediated, or genetic factors. The main clinical features include neuropathic pain and autonomic disturbance, which are occasionally disclaimed due to outstanding fatigue, daily performance decline, anxiety, and depression. As clinical, neurological, nerve conduction, and electromyography studies are commonly normal, diagnosis often depends on the finding of decreased intra-epidermal density of nerve fibers, per skin biopsy. This review highlights the etiology, clinical, diagnostic aspects, and SFN treatment.

Keywords: Autoimmune diseases; Neuropathic pain; Sarcoidosis; Small-fiber neuropathy.

Publication types

  • Review

MeSH terms

  • Humans
  • Peripheral Nervous System Diseases / diagnosis*
  • Peripheral Nervous System Diseases / etiology
  • Peripheral Nervous System Diseases / genetics
  • Peripheral Nervous System Diseases / therapy*